MAIA Biotechnology Inc (MAIA) Stock Price

1.26 ▼ -0.10 (-7.35%)
Open: 1.33 Vol: 541.94K Day's range: 1.255 - 1.36 May 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MAIA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.26▲ 1.27▲ 1.27▲ 1.31▼ 1.31▼
MA10 1.26▲ 1.27▼ 1.29▼ 1.33▼ 1.35▼
MA20 1.27▲ 1.29▼ 1.30▼ 1.32▼ 1.66▼
MA50 1.28▼ 1.30▼ 1.31▼ 1.37▼ 1.57▼
MA100 1.29▼ 1.32▼ 1.32▼ 1.65▼ 1.96▼
MA200 1.30▼ 1.32▼ 1.32▼ 1.53▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.003▼ -0.004▼ 0.005▲ -0.050▼
RSI 50.457▲ 43.755▼ 43.500▼ 42.501▼ 42.560▼
STOCH 25.000     19.342▼ 8.772▼ 34.101     18.673▼
WILL %R 0.000▲ -89.474▼ -89.474▼ -86.111▼ -92.308▼
CCI 24.561     -59.373     -82.731     -92.587     -63.217    
Latest Filters Detected On MAIA
RSI $MAIA RSI(14) Crossed Below 50 Set Alert
MA $MAIA Price Crossed Below MA(26) Set Alert
MA $MAIA Price Crossed Below MA(13) Set Alert
MA $MAIA Price Crossed Below MA(7) Set Alert
▼ GAP $MAIA Open Gap Down %2 Set Alert
MAIA Biotechnology Inc News
MAIA 's Outlines 2026 Milestones On Ateganosine In Cancer Treatment Program; Stock Down
Tuesday, January 20, 2026 11:01 PM
(RTTNews) - MAIA Biotechnology, Inc. (MAIA), a clinical-stage immuno-oncology company, provided 2025 corporate highlights, including Ateganosine, MAIA's lead drug for non-small cell lung cancer, and ...
MAIA Biotechnology (MAIA) Price Target Decreased by 13.32% to 12.38
Monday, November 17, 2025 06:47 AM
The average one-year price target for MAIA Biotechnology (NYSEAM:MAIA) has been revised to $12.38 / share. This is a decrease of 13.32% from the prior estimate of $14.28 dated November 7, 2025. The ...
MAIA Biotechnology's Experimental Cancer Drug Shows Tripled Survival Vs. Standard Chemotherapy In Pretreated Lung Cancer Patients
Wednesday, June 04, 2025 05:00 PM
MAIA Biotechnology, Inc. (NASDAQ:MAIA) on Thursday revealed updated data from its THIO-101 pivotal Phase 2 clinical trial. The trial is evaluating its lead clinical candidate, ateganosine (THIO), ...
MAIA historical stock data
date open high low close volume
15/05/26 1.33 1.36 1.255 1.26 541,941
14/05/26 1.31 1.36 1.26 1.36 553,270
13/05/26 1.30 1.34 1.28 1.29 391,332
12/05/26 1.31 1.3994 1.23 1.31 737,660
11/05/26 1.29 1.36 1.29 1.31 626,362
08/05/26 1.30 1.35 1.26 1.32 305,466
07/05/26 1.39 1.39 1.29 1.31 272,858
06/05/26 1.36 1.446 1.34 1.35 1,012,657
05/05/26 1.36 1.436 1.36 1.39 411,166
04/05/26 1.35 1.43 1.34 1.39 785,566
Quote Details
52wk Low:0.87
52wk High:3.19
Vol:541.94K
Avg Vol(3m):16.2M
1Y Chng:-28.00%
1M Chng:-2.33%
Add to Watch List
More Information
Index N/A
Market Cap. 82.69M